Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-Resistant Pancreatic Cancer

Gastroenterology · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles